NCT01366430

Brief Summary

The purpose of this study was to compare the immediate efficacies of each treatment maneuvers in treatment of geotorpic horizontal canal benign paroxysmal positional vertigo (HC-BPPV).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2009

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 31, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 6, 2011

Completed
Last Updated

June 6, 2011

Status Verified

January 1, 2009

Enrollment Period

2.2 years

First QC Date

May 31, 2011

Last Update Submit

June 2, 2011

Conditions

Keywords

BPPV(benign paroxysmal positional vertigo)HC-BPPV(BPPV involving the horizontal semicircular canal)NystagmusTreatment outcomeHorizontal Canal Benign Paroxysmal Positional Vertigo

Outcome Measures

Primary Outcomes (1)

  • Immediate therapeutic effects for the treatment of geotropic HC-BPPV

    The immediate treatment response was determined by participating neurologists in each clinic without knowing the maneuver applied to each patient from 30 minutes to one hour after initial maneuver. The absence of both vertigo and nystagmus was required to determine a resolution. When the patient still showed positioning nystagmus or vertigo, the patient received the previously applied maneuver again.

    one hour

Study Arms (3)

Gefoni manenuver

ACTIVE COMPARATOR

Gefoni manenuver for Geotropic HC-BPPV

Procedure: Gufoni

sham maneuver

ACTIVE COMPARATOR

sham maneuver for geotropic HC-BPPV

Procedure: Sham

barbecue maneuver

ACTIVE COMPARATOR

barbecue maneuver for geotropic HC-BPPV

Procedure: Barbecue

Interventions

GufoniPROCEDURE

For Gufoni maneuver, the patient was quickly brought down on the healthy side from the sitting position, and the head was then turned about 45 degree down, so that the nose was on the bed. After 2 minutes in this position, the patient was returned to the upright position.

Gefoni manenuver
ShamPROCEDURE

The sham maneuver the opposite of the first step for barbecue rotation; lying down from sitting position for 30 seconds, and head turn 90degree to the affected side for 1 minute, and then sit up.

sham maneuver
BarbecuePROCEDURE

For barbecue rotation, the head was rotated rapidly 90degree while supine in the direction of the healthy ear, which was immediately followed by a truncal rotation of 90degree in the same direction to lie on the intact side. After 30-60 seconds when the induced nystagmus was dissipated, the patients were subjected to a further 90degree rotation of the head and trunk en block in the same direction to attain the nose-down position. After a further 30-60 seconds, the head was again turned in the same direction so that the affected ear was downward. Finally, after another 30-60s, the patient was brought to sitting position. Only one maneuver was performed per session.

barbecue maneuver

Eligibility Criteria

Age11 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • a history of brief episodes of positional vertigo, direction-changing horizontal nystagmus beating toward the uppermost (apogeotropic nystagmus) ear in both the lateral head turning positions,
  • no spontaneous nystagmus during upright sitting position
  • absence of identifiable central nervous system disorders that could explain the positional vertigo and nystagmus

You may not qualify if:

  • central positional nystagmus with identifiable CNS lesions that could explain the positional nystagmus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Chonbuk National University Hospital

Jeonju, Cholabuk-do, 560-712, South Korea

Location

Chonnam National University Hospital

Kwangju, Cholanam-do, South Korea

Location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Location

MeSH Terms

Conditions

Benign Paroxysmal Positional VertigoNystagmus, Pathologic

Interventions

salicylhydroxamic acid

Condition Hierarchy (Ancestors)

VertigoVestibular DiseasesLabyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOcular Motility DisordersCranial Nerve DiseasesEye Diseases

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 31, 2011

First Posted

June 6, 2011

Study Start

January 1, 2009

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

June 6, 2011

Record last verified: 2009-01

Locations